Compound class:
Synthetic organic
Comment: T3 is a PROTAC degrader that simultaneously targets alpha-synuclein (α-Syn) and tau proteins [1]. It was developed for potential to reduce pathological α-Syn and tau aggregations for application as a neurodegenerative disease therapy. The target protein warhead binds both α-Syn and tau, and the cereblon E3 ubiquitin ligase is engaged by a pomalidomide moiety.
|
|
References |
1. Zhu W, Zhang W, Chen J, Tong Y, Xu F, Pang J. (2024)
Discovery of Effective Dual PROTAC Degraders for Neurodegenerative Disease-Associated Aggregates. J Med Chem, 67 (5): 3448-3466. [PMID:38356330] |